Pauls Matthew

CIK 00015734297 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001573429

Recent Transactions

50 trades

Sale
Pelthos Therapeutics Inc.$PTHS
Common Stock
2026-07-02$27.36/sh−94→ 14,364 total
Sale
Pelthos Therapeutics Inc.$PTHS
Common Stock
2026-07-02$26.00/sh−692→ 14,458 total
Award
PALVELLA THERAPEUTICS, INC.$PVLA
Stock Option (Right to Buy)
2026-06-29+6,000→ 6,000 total
Disposition to Issuer
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2026-05-18−10,491→ 0 total
Disposition to Issuer
SOLENO THERAPEUTICS INC$SLNO
Stock Option (Right to buy)
2026-05-18−9,063→ 0 total
Sale
Pelthos Therapeutics Inc.$PTHS
Common Stock
2026-04-02$20.52/sh−415→ 15,521 total
Sale
Pelthos Therapeutics Inc.$PTHS
Common Stock
2026-04-02$21.36/sh−371→ 15,150 total
Gift
Savara Inc$SVRA
Common Stock
2025-12-16−128,995→ 1,188,050 total
Tax Payment
Savara Inc$SVRA
Common Stock
2025-12-14$6.92/sh−195,705→ 1,317,045 total
Gift
Savara Inc$SVRA
Common Stock
2025-12-10−23,629→ 1,512,750 total
Gift
Pelthos Therapeutics Inc.$PTHS
Common Stock
2025-12-10−9,542→ 1,074 total
Exercise/Conversion
Pelthos Therapeutics Inc.$PTHS
Restricted Stock Units
2025-10-02−2,123→ 14,862 total
Exercise/Conversion
Pelthos Therapeutics Inc.$PTHS
Common Stock
2025-10-02+2,123→ 10,616 total
Exercise/Conversion
Pelthos Therapeutics Inc.$PTHS
Restricted Stock Units
2025-07-02−8,493→ 16,985 total
Award
Pelthos Therapeutics Inc.$PTHS
Stock Option
2025-07-02+77,640→ 77,640 total
Award
Pelthos Therapeutics Inc.$PTHS
Restricted Stock Units
2025-07-02+25,478→ 25,478 total
Exercise/Conversion
Pelthos Therapeutics Inc.$PTHS
Common Stock
2025-07-02+8,493→ 8,493 total
Award
Pelthos Therapeutics Inc.$PTHS
Common Stock
2025-07-02+25,478→ 25,478 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2025-06-05+3,991→ 10,491 total
Exercise/Conversion
SOLENO THERAPEUTICS INC$SLNO
Employee stock option (right to buy)
2025-03-28−5,937→ 9,063 total
Exercise/Conversion
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2025-03-28$4.60/sh+5,937→ 12,437 total
Sale
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2025-03-28$71.55/sh−5,937→ 6,500 total
Sale
Savara Inc$SVRA
Common Stock
2024-12-16$3.31/sh−54,702→ 1,536,379 total
Tax Payment
Savara Inc$SVRA
Common Stock
2024-12-13$3.21/sh−92,593→ 1,591,081 total
Award
Savara Inc$SVRA
Common Stock
2024-12-12+400,000→ 1,683,674 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2024-12-12+900,000→ 900,000 total
Award
SOLENO THERAPEUTICS INC$SLNO
Common Stock
2024-06-06+6,500→ 6,500 total
Sale
Savara Inc$SVRA
Common Stock
2023-12-28$4.71/sh−84,000→ 1,302,674 total
Gift
Savara Inc$SVRA
Common Stock
2023-12-28−19,000→ 1,283,674 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2023-12-14+225,000→ 225,000 total
Tax Payment
Savara Inc$SVRA
Common Stock
2023-12-14$4.45/sh−109,680→ 936,674 total
Award
Savara Inc$SVRA
Common Stock
2023-12-14+450,000→ 1,386,674 total
Award
SOLENO THERAPEUTICS INC$SLNO
Stock option (right to buy)
2023-08-15+15,000→ 15,000 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2022-12-13+700,000→ 700,000 total
Award
Savara Inc$SVRA
Common Stock
2022-12-13+325,000→ 1,046,354 total
Tax Payment
Savara Inc$SVRA
Common Stock
2021-12-31$1.24/sh−62,318→ 721,354 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2021-12-14+350,000→ 350,000 total
Award
Savara Inc$SVRA
Common Stock
2021-12-14+400,000→ 783,672 total
Purchase
Savara Inc$SVRA
Common Stock
2021-12-08$1.06/sh+6,500→ 383,672 total
Purchase
Savara Inc$SVRA
Common Stock
2021-12-02$1.10/sh+10,000→ 377,172 total
Purchase
Savara Inc$SVRA
Common Stock
2021-11-19$1.06/sh+2,150→ 367,172 total
Purchase
Savara Inc$SVRA
Common Stock
2021-11-19$1.11/sh+10,000→ 365,022 total
Purchase
Savara Inc$SVRA
Common Stock
2021-11-18$1.10/sh+10,000→ 355,022 total
Purchase
Savara Inc$SVRA
Common Stock
2021-08-18$1.19/sh+11,900→ 345,022 total
Purchase
Savara Inc$SVRA
Common Stock
2021-08-17$1.18/sh+15,000→ 333,122 total
Purchase
Savara Inc$SVRA
Common Stock
2021-05-21$1.63/sh+10,000→ 318,122 total
Purchase
Savara Inc$SVRA
Common Stock
2021-04-19$1.82/sh+27,400→ 308,122 total
Purchase
Savara Inc$SVRA
Common Stock
2021-03-22$2.07/sh+24,100→ 280,722 total
Purchase
Savara Inc$SVRA
Common Stock
2021-02-22$1.74/sh+28,700→ 256,622 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2020-12-16+500,000→ 500,000 total

Companies

Recent Filings

Address

C/O PELTHOS THERAPEUTICS INC. 4020 STIRRUP CREEK DRIVE, SUITE 110

DURHAM, NC, 27703

View on SEC.gov